BioxTech has newly appeared among the top searched stocks.


As of 10:30 AM on the 20th, BioxTech is trading at 15,500 KRW, down 3.43% from the previous day. This represents a 46.23% increase compared to October 30. BioxTech is known as a leading domestic CRO company specializing in non-clinical trials.

Over the past five days, individual investors have net purchased 46,051 shares, while foreign investors have net sold 40,779 shares.


On November 19, BioxTech became a market issue with the news "Second largest shareholder Celltrion's possibility of contract manufacturing Pfizer vaccines ↑".



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing